Company News

Copley Scientific invests locally and boosts rate of growth Medmeme makes new senior sales appointment ACG Group appoints Richard Stedman as Group CEO Tetra Bio-Pharma appoints Bernard Fortier CEO Johnson Matthey turns 200 years old Chris Rombach joins ChargePoint aiding US expansion following multi-million-pound investment Surfachem appoints Dr Philip Wright as Strategic Business Development Manager The Royal Society announces Croonian Medallist 2018 Prof J Dressman joins Certara’s Simcyp Scientific Advisory Board Hubbard and Daikin united in commercial refrigeration TricorBraun announce new management positions Allied Minds subsidiary BridgeSat appoint Barry Matsumori CEO Cyclists Chiara Ricciardo and Riccardo Rocchi raise diabetes awareness Pharma companies still searching for answers on gender diversity Concept Life Sciences appoints Dr Andrew Clifton BioAscent appoints new CEO and plans to expand discovery services PharmaLex Group strengthens biosimilar expertise PCI Clinical Services welcomes Jamie Weishaar to North American Clinical Sales Team ASLAN Pharmaceuticals CEO Dr Carl Firth appointed to IAC singapore Intelligent Fingerprinting strengthens R&D team appointing Alan Pang New National Distribution Manager for Hi-line Industries West appoints Alessandra Rispoli Senior Director of Operations GEA appoints Martine Snels as new member to the Executive Board Oxford BioDynamics appoint Paul Stockdale CFO

Trending Articles

  1. THX Pharma appoints Julien Veys as deputy chief executive officer Leadership appointment supports the company’s strategy to advance regulatory approval and commercialization of rare neurology therapies
  2. Kindeva announces leadership transition to support strategic growth David Stevens assumes CEO role as part of a planned succession strategy
  3. Astoriom appoints Will Edwards as Chief Executive Officer Strategic appointment to support global scale-up of sample management operations
  4. Rentschler Biopharma appoints Detra Glinatsis as head of U.S. business development Glinatsis returns to lead U.S. growth strategy and build on Milford site expansion
  5. Seasoned biotherapeutics leader Thomas J. Farrell joins NanoSyrinx as CEO Appointment supports NanoSyrinx’s transition from platform development to clinical-stage intracellular medicines

Upcoming event

High Shear = Mixing Success

19 February 2026 | Virtual See all